4 Key Takeaways | Solar Industry & Chinese Tariff Update
Hot Topics in International Trade- A Year in Review (Quickly) with Braumiller Law Group Attorney Brandon French
Hot Topics in International Trade A Year in Review (Quickly)
Hot Topics in International Trade. Deep Thoughts by Bob Braumiller Law Group & Consulting Group Podcasts
Hot Topics in International Trade. Section 301-China Tariffs, With Associate Attorney Brandon French, Braumiller Law Group
Fashion and Retail Opportunities for Major Duty Savings and What to Know Now About Forced Labor
US China Tariffs and Your Supply Chain
WorldSmart: The Impact of Export Control and Economic Sanctions on International Business
Podcast: How the First Sale Rule Can Lower Your Duties by up to 30%
Our International Trade team comments on the escalating U.S.—China trade conflict
Nota Bene Episode 40: Revisiting the U.S. Trade War and China’s Ascent as an Economic Power with Scott Maberry
Escalating U.S.- China Trade Conflict
Could A US-EU Free Trade Deal Harm The WTO?
On May 14, 2024, the United States Trade Representative (USTR) released its Final Report relating to the four-year review of actions taken in the Section 301 investigation. Within the Report, the USTR confirmed that it...more
As reported in our previous client alert, on May 14, 2024, President Biden announced that he directed his Trade Representative to increase tariffs under Section 301 of the Trade Act of 1974 (Section 301) on a wide range of...more
On May 27, 2022, the Office of the US Trade Representative (USTR) published a Federal Register notice extending Section 301 tariff exclusions for certain China-origin medical products needed to address the COVID-19 pandemic....more
As the country continues to experience the effects of the COVID-19 pandemic, the Office of the US Trade Representative (USTR) has invited public comments on whether to continue excluding certain medical supplies from the...more
On March 10, 2021, the United States Trade Representative (USTR) published an extension of the COVID-19 related medical-care and response product exclusions from Section 301 duties covering imports from China. The agency...more
On December 29, 2020, the U.S. Trade Representative (USTR) posted a notice granting new Section 301 product exclusions and extending existing exclusions for COVID-19 medical care products. This action is in response to USTR’s...more
The COVID-19 pandemic is significantly disrupting international trade as global and domestic supply chains grapple with declining trade volumes and inadequate supplies of medical goods, including personal protective equipment...more
The Office of the U.S. Trade Representative (USTR) has issued a call for comments regarding the possible removal of Section 301 tariffs for medical-care products from China. The request for comments on the easing of Section...more
Many U.S. manufacturers that rely on Chinese-origin goods have been paying steep tariffs of up to 25% on the import of Chinese goods due to special Section 301 tariffs. Because these tariffs were applied to the vast majority...more
The Office of the U.S. Trade Representative (USTR) has announced it is accepting comments on potential Section 301 tariff exclusions for Chinese imports necessary to respond to the coronavirus. USTR is likely to expeditiously...more
On March 25, 2020, the United States Trade Representative (“USTR”) issued new product exclusions pertaining to the 7.5% Section 301 List 4A Tariffs. The new list of exclusions includes five 10-digit HTS subheadings and seven...more
On March 25, 2020, the Office of the U.S. Trade Representative (USTR) published a Federal Register Notice requesting public comments on possible further modifications to remove Section 301 duties from additional...more
On Wednesday, March 25, 2020, the U.S. Trade Representative (USTR) published a Federal Register notice requesting comments on the removal of Section 301 tariffs from Chinese medical-care products—including those that have...more
On Friday, March 20, 2020, in an effort to fight against the coronavirus pandemic, the U.S. Trade Representative (USTR) announced that it is accepting exclusions requests to remove tariffs imposed on Chinese origin...more
The Office of the U.S. Trade Representative (USTR) recently published several Federal Register Notices (March 10, 16, and 17, 2020) announcing new granted exclusions for List 3 goods (currently 25 percent) and List 4A goods...more
In response to the COVID-19 outbreak, USTR issued a Federal Register Notice requesting public comments on the possibility of removing the application of China Section 301 duties from medical care products, including inputs...more
- Late on Friday, March 20, 2020, USTR announced that it has opened a new public comment period for businesses and government agencies to request additional product exclusions from Section 301 duties for certain...more
On March 6, 2020, the United States Trade Representative (“USTR”) issued product exclusions pertaining to the 7.5% Section 301 List 4A Tariffs. The new list of exclusions includes 8 10-digit HTS subheadings that cover 59...more